Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Sarcoma Center at Dana-Farber Cancer Institute — one of the largest and most respected sarcoma programs in the world — is leading critical efforts toward understanding the specific genetic changes that cause sarcomas. New findings
inform the design of innovative diagnostic techniques and treatments. Our recent investigations — of unprecedented depth and scope — aim to increase treatment efficacy through research into resistance mechanisms and novel therapeutics.
Diseases for which we conduct clinical trials include:
Read about our research for angiosarcomas.
Read about our research for Ewing's sarcoma.
Read about our research for GIST.
Read about our research for leiomyosarcoma and deconstructing heterogeneity in leiomyosarcoma.
Read about our research for liposarcoma.
Read about our research for osteosarcoma.
Read about our research for TGCT.
Find Dana-Farber's clinical trials for sarcoma.
New Patient Appointments
Clinical Trials Questions?